SG11201503997VA - Functionalized benzamide derivatives as antiviral agents against hbv infection - Google Patents
Functionalized benzamide derivatives as antiviral agents against hbv infectionInfo
- Publication number
- SG11201503997VA SG11201503997VA SG11201503997VA SG11201503997VA SG11201503997VA SG 11201503997V A SG11201503997V A SG 11201503997VA SG 11201503997V A SG11201503997V A SG 11201503997VA SG 11201503997V A SG11201503997V A SG 11201503997VA SG 11201503997V A SG11201503997V A SG 11201503997VA
- Authority
- SG
- Singapore
- Prior art keywords
- antiviral agents
- hbv infection
- agents against
- benzamide derivatives
- against hbv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261734184P | 2012-12-06 | 2012-12-06 | |
PCT/US2013/073319 WO2014089296A2 (en) | 2012-12-06 | 2013-12-05 | Functionalized benzamide derivatives as antiviral agents against hbv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201503997VA true SG11201503997VA (en) | 2015-06-29 |
Family
ID=50884140
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201900695PA SG10201900695PA (en) | 2012-12-06 | 2013-12-05 | Functionalized benzamide derivatives as antiviral agents against hbv infection |
SG11201503997VA SG11201503997VA (en) | 2012-12-06 | 2013-12-05 | Functionalized benzamide derivatives as antiviral agents against hbv infection |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201900695PA SG10201900695PA (en) | 2012-12-06 | 2013-12-05 | Functionalized benzamide derivatives as antiviral agents against hbv infection |
Country Status (13)
Country | Link |
---|---|
US (2) | US20150307443A1 (en) |
EP (1) | EP2928459A4 (en) |
JP (2) | JP6353460B2 (en) |
KR (1) | KR20150090219A (en) |
CN (2) | CN110642741A (en) |
AU (2) | AU2013355220B2 (en) |
BR (1) | BR112015013121A2 (en) |
CA (1) | CA2892606A1 (en) |
IL (1) | IL238930B (en) |
NZ (2) | NZ708392A (en) |
PH (1) | PH12015501276A1 (en) |
SG (2) | SG10201900695PA (en) |
WO (1) | WO2014089296A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201504740UA (en) * | 2012-12-27 | 2015-07-30 | Univ Drexel | Novel antiviral agents against hbv infection |
DK3116316T3 (en) | 2014-03-13 | 2019-08-19 | Univ Indiana Res & Tech Corp | ALLOSTERIC MODULATORS OF HEPATITIS B CORE PROTEIN |
WO2016177655A1 (en) * | 2015-05-04 | 2016-11-10 | F. Hoffmann-La Roche Ag | Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections |
TWI730985B (en) | 2015-09-15 | 2021-06-21 | 美商艾森伯利生物科學公司 | Hepatitis b core protein modulators |
JOP20190024A1 (en) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | Substituted pyrrolizine compounds and uses thereof |
CA3036245C (en) | 2016-09-13 | 2021-07-20 | Arbutus Biopharma Corporation | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same |
WO2018053157A1 (en) | 2016-09-15 | 2018-03-22 | Assembly Biosciences, Inc. | Hepatitis b core protein modulators |
CN110114071B (en) | 2016-11-07 | 2023-07-04 | 爱彼特生物制药公司 | Tricyclic compounds containing substituted pyridones and methods of using the same |
CA3055194A1 (en) | 2017-03-02 | 2018-09-07 | Assembly Biosciences, Inc. | Cyclic sulfamide compounds and methods of using same |
WO2018172852A1 (en) | 2017-03-21 | 2018-09-27 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
EP3759109B1 (en) | 2018-02-26 | 2023-08-30 | Gilead Sciences, Inc. | Substituted pyrrolizine compounds as hbv replication inhibitors |
CN112724037B (en) * | 2018-06-13 | 2022-03-11 | 浙江大学 | Hydroxyl benzene salicylamine hydroxylate, preparation method and application thereof |
MA53983A (en) | 2018-10-22 | 2021-12-15 | Assembly Biosciences Inc | 5-MEMBER HETEROARYL CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF HBV |
EP3873488A4 (en) | 2018-10-31 | 2022-08-03 | The University of Sydney | Compositions and methods for treating viral infections |
TWI827760B (en) | 2018-12-12 | 2024-01-01 | 加拿大商愛彼特生物製藥公司 | Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using same |
BR112021023622A2 (en) | 2019-05-24 | 2022-04-19 | Assembly Biosciences Inc | Pharmaceutical compositions for the treatment of hbv |
EP4139000A1 (en) | 2020-04-22 | 2023-03-01 | Assembly Biosciences, Inc. | Pyrazole carboxamide compounds for treatment of hbv |
WO2021216661A1 (en) | 2020-04-22 | 2021-10-28 | Assembly Biosciences, Inc. | Pyrazole carboxamide compounds for treatment of hbv |
WO2021216656A1 (en) | 2020-04-22 | 2021-10-28 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of hbv |
WO2021216660A1 (en) | 2020-04-22 | 2021-10-28 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of hbv |
US20210371388A1 (en) * | 2020-05-12 | 2021-12-02 | Baruch S. Blumberg Institute | Bicyclic Carboxamide with Exocyclic Urea Derivatives as Antivirals for the Treatment of HBV Infection |
TW202214574A (en) * | 2020-06-08 | 2022-04-16 | 加拿大商愛彼特生物製藥公司 | Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl)amides, and analogues thereof |
WO2023069547A1 (en) | 2021-10-20 | 2023-04-27 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of hbv |
WO2023069544A1 (en) | 2021-10-20 | 2023-04-27 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of hbv |
WO2023069545A1 (en) | 2021-10-20 | 2023-04-27 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of hbv |
WO2023164186A1 (en) | 2022-02-25 | 2023-08-31 | Assembly Biosciences, Inc. | Benzothia(dia)zepine compounds for treatment of hbv and hdv |
WO2023164179A1 (en) | 2022-02-25 | 2023-08-31 | Assembly Biosciences, Inc. | Benzothia(dia)zepine compounds for treatment of hbv and hdv |
WO2023164183A1 (en) | 2022-02-25 | 2023-08-31 | Assembly Biosciences, Inc. | Benzothia(dia)zepine compounds for treatment of hbv and hdv |
WO2023164181A1 (en) | 2022-02-25 | 2023-08-31 | Assembly Biosciences, Inc. | Benzothia(dia)zepine compounds for treatment of hbv and hdv |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108459A0 (en) * | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
JPH06297860A (en) * | 1993-04-14 | 1994-10-25 | New Oji Paper Co Ltd | Heat-sensitive recording body |
DK1037880T3 (en) * | 1997-12-11 | 2004-11-15 | Janssen Pharmaceutica Nv | Anilides such as retinoic acid mimetics |
US6653309B1 (en) * | 1999-04-26 | 2003-11-25 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme technical field of the invention |
AU2001269092A1 (en) * | 2000-06-27 | 2002-01-08 | Axxima Pharmaceuticals Ag | Inhibitors of hepatitis b virus infection |
DE10109856A1 (en) * | 2001-03-01 | 2002-09-05 | Bayer Ag | Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
US7176227B2 (en) * | 2002-09-11 | 2007-02-13 | Kureha Corporation | Amine compounds and use thereof |
US7696244B2 (en) * | 2003-05-16 | 2010-04-13 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
SE0401342D0 (en) * | 2004-05-25 | 2004-05-25 | Astrazeneca Ab | Therapeutic compounds |
US20070161648A1 (en) * | 2005-10-14 | 2007-07-12 | Hughes Terry V | Substituted dihydro-isoindolones useful in treating kinase disorders |
CN1951932B (en) * | 2005-10-20 | 2010-11-24 | 北京科莱博医药开发有限责任公司 | [N-(3',4'-methylenedioxy) phenylethyl] carboxamido benzoic acid derivatives, processes for their preparation and their use |
MY162590A (en) * | 2005-12-13 | 2017-06-30 | Incyte Holdings Corp | Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors |
US20100022547A1 (en) * | 2006-06-02 | 2010-01-28 | Brandeis University | Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
DE102006060598A1 (en) * | 2006-12-21 | 2008-06-26 | Merck Patent Gmbh | New tetrahydrobenzoisoxazole compounds are mitotic motor protein Eg5 modulators useful to treat and prevent cancer, and to treat e.g. monocyte leukemia, glioblastoma, colon carcinoma, myelotic leukemia and lymphatic leukemia |
AU2008235212B2 (en) * | 2007-04-09 | 2014-01-16 | Methylgene Inc. | Inhibitors of histone deacetylase |
CA2715960A1 (en) * | 2007-12-27 | 2009-07-09 | F. Hoffmann-La Roche Ag | Insulin-degrading enzyme crystals |
BRPI0922366B8 (en) * | 2008-12-03 | 2021-05-25 | Presidio Pharmaceuticals Inc | compound, pharmaceutical composition and use of a compound |
EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
WO2012058378A1 (en) * | 2010-10-29 | 2012-05-03 | Romark Laboratories L.C. | Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses |
BR112013023798A2 (en) * | 2011-03-22 | 2016-09-20 | Syngenta Participations Ag | insecticide compounds |
WO2012135697A2 (en) * | 2011-03-30 | 2012-10-04 | H. Lee Moffitt Cancer Center & Research Institute Inc. | Novel rho kinase inhibitors and methods of use |
-
2013
- 2013-12-05 NZ NZ708392A patent/NZ708392A/en not_active IP Right Cessation
- 2013-12-05 NZ NZ748966A patent/NZ748966A/en not_active IP Right Cessation
- 2013-12-05 CA CA2892606A patent/CA2892606A1/en not_active Abandoned
- 2013-12-05 KR KR1020157017223A patent/KR20150090219A/en not_active Application Discontinuation
- 2013-12-05 US US14/650,159 patent/US20150307443A1/en not_active Abandoned
- 2013-12-05 CN CN201910903071.5A patent/CN110642741A/en active Pending
- 2013-12-05 AU AU2013355220A patent/AU2013355220B2/en not_active Ceased
- 2013-12-05 SG SG10201900695PA patent/SG10201900695PA/en unknown
- 2013-12-05 CN CN201380065824.0A patent/CN104918612B/en not_active Expired - Fee Related
- 2013-12-05 JP JP2015545840A patent/JP6353460B2/en not_active Expired - Fee Related
- 2013-12-05 EP EP13859675.4A patent/EP2928459A4/en not_active Withdrawn
- 2013-12-05 WO PCT/US2013/073319 patent/WO2014089296A2/en active Application Filing
- 2013-12-05 BR BR112015013121A patent/BR112015013121A2/en not_active IP Right Cessation
- 2013-12-05 SG SG11201503997VA patent/SG11201503997VA/en unknown
-
2015
- 2015-05-20 IL IL238930A patent/IL238930B/en not_active IP Right Cessation
- 2015-06-05 PH PH12015501276A patent/PH12015501276A1/en unknown
-
2018
- 2018-06-08 JP JP2018109976A patent/JP2018162272A/en active Pending
- 2018-11-01 AU AU2018256602A patent/AU2018256602A1/en not_active Abandoned
- 2018-11-28 US US16/202,822 patent/US20190092720A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2892606A1 (en) | 2014-06-12 |
CN104918612B (en) | 2019-10-25 |
JP2018162272A (en) | 2018-10-18 |
JP2016506387A (en) | 2016-03-03 |
AU2018256602A1 (en) | 2018-11-22 |
AU2013355220A1 (en) | 2015-06-18 |
IL238930B (en) | 2020-06-30 |
EP2928459A2 (en) | 2015-10-14 |
WO2014089296A3 (en) | 2014-08-07 |
SG10201900695PA (en) | 2019-02-27 |
JP6353460B2 (en) | 2018-07-04 |
NZ708392A (en) | 2020-05-29 |
IL238930A0 (en) | 2015-07-30 |
NZ748966A (en) | 2020-05-29 |
BR112015013121A2 (en) | 2017-07-11 |
US20190092720A1 (en) | 2019-03-28 |
AU2013355220B2 (en) | 2018-08-02 |
US20150307443A1 (en) | 2015-10-29 |
CN110642741A (en) | 2020-01-03 |
WO2014089296A2 (en) | 2014-06-12 |
CN104918612A (en) | 2015-09-16 |
KR20150090219A (en) | 2015-08-05 |
EP2928459A4 (en) | 2016-10-26 |
PH12015501276A1 (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL238930A0 (en) | Functionalized benzamide derivatives as antiviral agents against hbv infection | |
IL258007A (en) | Novel antiviral agents against hbv infection | |
HRP20181384T1 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
HK1245263A1 (en) | Antiviral compounds | |
EP2726459A4 (en) | Sulfamoylbenzamide derivatives as antiviral agents against hbv infection | |
HRP20171351T1 (en) | Rsv antiviral compounds | |
SG10201703451RA (en) | Antiviral compounds | |
HK1204618A1 (en) | Antiviral compounds | |
EP2926662A4 (en) | Silicon-containing compound aqueous solution and antibacterial/antiviral agent including said solution | |
IL234747A0 (en) | Vesicular formulations | |
EP2664621A4 (en) | Antiviral agent | |
HK1202249A1 (en) | Vesicular formulations | |
GB201223187D0 (en) | Formula 1- 2050 | |
GB201222981D0 (en) | Formula 1 -2050 | |
GB201222964D0 (en) | Formula 1 - 2050 |